We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Philips to Acquire Adac Laboratories for $426 Million

By HospiMedica staff writers
Posted on 20 Nov 2000
Print article
Royal Philips Electronics (Amsterdam, The Netherlands) has agreed to acquire Adac Laboratories (Milpitas, CA, USA) for around US$426 million. The acquisition will enable Philips Medical Systems (Best, The Netherlands) to offer healthcare providers worldwide a broader range of systems to diagnose and treat such diseases as cardiovascular disease and cancer. Adac's revenues for the fiscal year 2000, ended October 1, were $324.4 million.

Adac Laboratories is a leading supplier of nuclear medicine imaging equipment and radiation therapy planning systems. The nuclear medicine systems are used primarily in the diagnosis of heart disease and cancer. Adac is also a growing presence in the positron emission tomography (PET) imaging market. Adac's line will complement and broaden the Philips line of products, which include catheterization labs, magnetic resonance (MR), computed tomography (CT), x-ray, and ultrasound systems as well as information technology addressing the radiology, general imaging, and surgical and cardiovascular markets.

"In cardiology, one of our focus areas, this acquisition will significantly complement our HeartCare program since nuclear medicine is one of the important tools clinicians rely on to assess cardiovascular disease,” said Hans Barella, president and CEO of Philips Medical Systems.



Related Links:
Philips Medical Systems
Adac Laboratories
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Medical Magnifier
EX-06
New
Tablet Cart
Tryten P1

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more